🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
VG161 is a recombinant human-IL12/15/PDL1B oncolytic HSV-1 Injectable. This...
Status
Unknown
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-03-08
Trial ID
NCT05162118
Phase I/II clinical trial on the per-operative intra-tumoral administration...
Status
Active Not Recruiting
Location
Universitair Ziekenhuis Brussel
Start Date
2016-11-17
Trial ID
NCT03233152
The goal of this clinical trial is to study the safety, feasibility, histol...
Status
Recruiting
Location
Hospital of the University of Pennsylvania
Start Date
2026-04-27
Trial ID
NCT07319195
Treatments Being Tested
The 1100 study is an open-label, Phase I, dose escalation and expansion pro...
Status
Active Not Recruiting
Location
University of California San Francisco
Start Date
2019-01-16
Trial ID
NCT03589339
Treatments Being Tested
VG161 is a recombinant human-IL12/15/PDL1B oncolytic HSV-1 injection. This ...
Status
Unknown
Location
Peking University Cancer Hospital
Start Date
2022-11-17
Trial ID
NCT06008925
Treatments Being Tested
The goal of this clinical trial is to learn whether intratumoral (injected ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07741565
Treatments Being Tested
Twelve patients with relapsed malignant pleural mesothelioma will be treate...
Status
Unknown
Location
Baylor College of Medicine
Start Date
2019-08-15
Trial ID
NCT04013334
Treatments Being Tested
Keynote 695 is Phase 2 study of intratumoral tavokinogene telseplasmid (tav...
Status
Unknown
Location
The University of Arizona Cancer Center
Start Date
2017-10-03
Trial ID
NCT03132675
Treatments Being Tested
This study seeks to estimate the occurrence of adverse events related to th...
Status
Completed
Location
Antelope Valley Urology & Incontinence
Start Date
2019-06-28
Trial ID
NCT04090775
Treatments Being Tested
This is a Phase 2, multicenter, open-label, 2-cohort (Locoregionally Advanc...
Status
Withdrawn
Location
University of California San Diego, UCSD
Start Date
2024-01-30
Trial ID
NCT05743270
Treatments Being Tested